Congratulations to the following individuals for obtaining extramural funding from federal, state, and/or independent sources between February 1 and April 30, 2020!
NOTE: The information below was provided to The Pulse. If there is any information
that was inadvertently omitted, please contact the editor (dflock@lsuhsc.edu) and a correction will be printed in the next issue of The Pulse.
National Institutes of Health (R01):
Nicolas Bazan, MD, PhD (Neuroscience Center of Excellence)
“RPE Messengers, Transcription and Photoreceptor Renewal”
Song Hong, PhD (Neuroscience Center of Excellence)
“Regenerative Lipid Mediators for the Management of Severe Burn Wounds”
National Institutes of Health (R00):
Michael Salling, PhD (Department of Cell Biology and Anatomy)
“Prefrontal Pathways Engaged in Excessive Alcohol Consumption”
National Institutes of Health (R21):
Jeffrey Erickson, PhD (Neuroscience Center of Excellence)
“Novel Riluzole Derivatives for Alzheimer's Disease”
Minghao Jin, PhD (Neuroscience Center of Excellence)
“RPE Apical Proteins that Regulate the Visual Cycle”
Foundations and National Associations:
Nicolas Bazan, MD, PhD (Neuroscience Center of Excellence)
Cleveland Clinic Foundation
“Downregulation of Senescence Programming in the Hypothalamus and Adipose Tissue
by Elovanoids Counteract Diabetes Onset and Progression”
Kara Mari De Felice, MD (Department of Medicine, Section of Gastroenterology)
Crohn's and Colitis Foundation of America, Inc.
“Crohn's and Colitis SPARC IBD”
Lucio Miele, MD, PhD (Department of Genetics)
Hyundai Hope on Wheels
“Hyundai Hope on Wheels COVID-19 Testing”
Ashley Wennerstrom, PhD, MPH (Department of Medicine, Section of Community and Population Medicine)
Robert Wood Johnson Foundation
“Evaluating the Impact of New Contracting Requirements for Louisiana's Managed Care
Organizations on Improving Population Health”
Jovanny Zabaleta, PhD (Department of Pediatrics)
Instituto Nacional de Cancerologia
“Protocol TGC-2: Identification of Changes in DNA Methylation and Gene Expression
Profiles, Associated with Clinical Response to Chemotherapeutic Treatment in Pediatric
Patients with Acute Leukemia”
Pharmaceutical and Company Grants:
Murtuza Ali, MD (Department of Medicine, Section of Cardiology)
Amgen, Inc.
“Amgen cvMOBIUS - Repatha Protocol 20180059: The Cardiovascular Multi-Dimensional
Observational Investigation of the Use of PCSK Inhibitors”
Yussef Bennani, MD, MPH (Department of Medicine)
Gilead Sciences, Inc.
“Gilead GS-US-200-4334 (CRO = PPD Development, LLC)”
Paul LeLorier, MD (Department of Medicine, Section of Cardiology)
Abbott Laboratories
Electrophysiology Fellowship Grant Award for FY 21
Bolin Liu, MD (Department of Genetics)
METAvivor Research and Support, Inc.
“METAvivor IGF-2 in Herceptin Refractory HER2-Positive Breast Cancer”
Navya Nair, MD, MPH (Department of Obstetrics and Gynecology)
Cordgenics, LLC
“Standard Chemotherapy vs Stem Cell Directed Chemotherapy in Recurrent Platinum Resistant
Ovarian Cancer”
Jason Wilson, MD (Department of Neurosurgery)
NuVasive, Inc.
Travel Grant